Prognostic model for risk stratification of de novo metastatic nasopharyngeal carcinoma patients treated with chemotherapy followed by locoregional radiotherapy-Reference-Cited by-同舟云学术

Prognostic model for risk stratification of de novo metastatic nasopharyngeal carcinoma patients treated with chemotherapy followed by locoregional radiotherapy

Published:2021-02 Issue:1 Volume:6 Page:100004
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Li W.-Z.,Hua X.,Xie D.-H.,Liang H.,Liu G.-Y.,Xia W.-X.,Xiang Y.-Q.

Funder

Guangdong Medical Research Foundation

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference32 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. The strength/weakness of the AJCC/UICC staging system (7th edition) for nasopharyngeal cancer and suggestions for future improvement;Lee;Oral Oncol,2012

3. Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy;Pan;Cancer,2016

4. Nasopharyngeal carcinoma;Chen;Lancet,2019

5. Treatment for metastatic nasopharyngeal carcinoma;Bensouda;Eur Ann Otorhinolaryngol Head Neck Dis,2011

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A nomogram based on nutritional and inflammatory parameters to predict DMFS and identify beneficiaries of adjuvant chemotherapy in IVA-stage nasopharyngeal carcinoma;BMC Cancer;2024-05-11

2. Effective of metastasis‐directed therapy for de novo metastatic nasopharyngeal carcinoma: A propensity score matched analysis;Head & Neck;2023-08-09

3. Prognostic value of pre-treatment FDG PET/CT SUVmax for metastatic lesions in de novo metastatic nasopharyngeal carcinoma following chemotherapy and locoregional radiotherapy;Cancer Imaging;2023-02-24

4. Development of a prognostic model to identify the metastatic nasopharyngeal carcinoma patients who may benefit from chemotherapy combination PD-1 inhibitor;Frontiers in Immunology;2023-01-17

5. Integrated strategies for chemotherapy cycles in nasopharyngeal carcinoma patients: Real-world data from two epidemic centers guiding decision-making;Chinese Journal of Cancer Research;2023